Liquidia Corp (LQDA)
12.53
+0.16
(+1.29%)
USD |
NASDAQ |
Apr 26, 16:00
12.53
0.00 (0.00%)
After-Hours: 20:00
Liquidia Revenue (TTM): 17.49M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.49M |
| September 30, 2023 | 18.32M |
| June 30, 2023 | 17.80M |
| March 31, 2023 | 16.94M |
| December 31, 2022 | 15.94M |
| September 30, 2022 | 13.79M |
| June 30, 2022 | 13.80M |
| March 31, 2022 | 13.26M |
| December 31, 2021 | 12.85M |
| September 30, 2021 | 10.38M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 |
| Date | Value |
|---|---|
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 2.707M |
| September 30, 2018 | 3.955M |
| June 30, 2018 | 5.606M |
| March 31, 2018 | 6.545M |
| December 31, 2017 | 7.258M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
10.38M
Minimum
Sep 2021
18.32M
Maximum
Sep 2023
15.06M
Average
14.87M
Median
Revenue (TTM) Benchmarks
| United Therapeutics Corp | 2.328B |
| AIM ImmunoTech Inc | 0.202M |
| Perspective Therapeutics Inc | 0.00 |
| Protalix BioTherapeutics Inc | 65.49M |
| Armata Pharmaceuticals Inc | -- |